Conference Coverage

Estrogen Replacement Therapy and Risk of Colon Cancer in Postmenopausal Women

Published in Cancer Weekly, April 10th, 1995

The results of several recent epidemiological studies suggest that estrogen replacement therapy in postmenopausal women may decrease their risk of subsequently developing colon or colorectal cancer, reported Eugenia E. Calle at the American Cancer Society's 37th Science Writers Seminar, held March 26-19, 1995, in New Orleans, Louisiana.

Incidence rates for colon cancer used to be higher in women, than in men, until recently. The use of estrogen replacement therapy (ERT) has become more commonplace during this same time period, suggesting a possible relationship. Dr. Calle remarked that the reasons for this association are not clear, therefore, she and her colleagues...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1995-04-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry